SOHM, Inc. (SHMN)
OTCMKTS
· Delayed Price · Currency is USD
0.0009
+0.0001 (12.50%)
Apr 23, 2025, 12:41 PM EDT
SOHM, Inc. Revenue
In the year 2012, SOHM, Inc. had annual revenue of $1.30M, down -3.27%. SOHM, Inc. had revenue of $291.24K in the quarter ending December 31, 2012, with 35.18% growth.
Revenue
1.30M
Revenue Growth
+115.16%
P/S Ratio
1.40
Revenue / Employee
8.94K
Employees
145
Market Cap
1.81M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
SS Innovations International | 20.65M |
Endo Inc. | 1.76B |
Veradigm | 588.02M |
Elite Pharmaceuticals | 70.00M |
Northwest Biotherapeutics | 1.38M |
Glass House Brands | 200.90M |
BioStem Technologies | 301.83M |
American Oncology Network | 1.76B |
SOHM, Inc. News
- 8 days ago - SOHM, Inc. Announces Patent Allowance/Approval in South Korea - Accesswire
- 14 days ago - SOHM, Inc. Shares an Exciting Expansion and Upcoming Presentation on ABBIE - Accesswire
- 17 days ago - SOHM, Inc. Launches New AI Team to Advance ABBIE System and Genome Editing Innovations - Accesswire
- 6 weeks ago - SOHM, Inc. Shares Groundbreaking Findings in ABBIE Technology - Accesswire
- 5 months ago - SOHM, Inc. Announce Dr. Wei Zhu Onboard as Senior Marketing and Sales Consultant - Accesswire
- 5 months ago - SOHM, Inc. Announces Allowances Of Japanese Patent Claims Received from Japan's Patent Office (特許庁, Tokkyochō, JPO) Protecting Transformative SOHM-ABBIE Genome Edited, SAGE Recombinant-Organisms, -Cells, -Secretomes, -Exosomes - Accesswire
- 6 months ago - SOHM, Inc. Announce Dr. David Zarling Onboard as Senior Product Development Advisor - Accesswire
- 7 months ago - SOHM, Inc. Continues to Build its IP Portfolio in the Gene Editing and Cell Engineering Space - Accesswire